About The Hummingbird Study
The Johns Hopkins Women’s Mood Disorders Center is one of the several sites participating in The Hummingbird Study, a new clinical research trial with Sage Therapeutics to study postpartum depression. The Hummingbird Study’s purpose is to evaluate the safety and effectiveness of an investigational medication in women with moderate to severe postpartum depression. The research study lasts about 37 days and includes a screening visit, a 3-day, in-patient hospital stay and four follow-up visits. The Women’s Mood Disorder Center is actively recruiting new moms, up to six months postpartum, to participate.
Postpartum depression in new moms
According to the National Institute of Mental Health, postpartum depression is a biological complication of pregnancy. During pregnancy, levels of certain hormones rise and then rapidly fall after giving birth. However, in some women, these hormone shifts may contribute to postpartum depression. Research indicates that between 15 and 20% of new moms struggle with postpartum depression.
The Mental Health Association of Maryland’s Healthy New Mom’s Campaign is interested in the outcomes of the Hummingbird Study, happening across the country. The preliminary results from the project have been very positive and we are hopeful for more informative data as the trial adds more subjects.
Learn more about the Hummingbird Study at www.thehummingbirdstudy.com. For more information about postpartum mood and anxiety disorders, visit www.healthynewmoms.org. To learn more about MHAMD’s Healthy New Moms Campaign and our outreach across the state, please visit, www.healthynewmoms.org.